Compare ALUR & DLXY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ALUR | DLXY |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3M | 15.5M |
| IPO Year | N/A | N/A |
| Metric | ALUR | DLXY |
|---|---|---|
| Price | $1.12 | $0.89 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.25 | N/A |
| AVG Volume (30 Days) | ★ 76.4K | 47.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.54 | N/A |
| P/E Ratio | ★ N/A | $11.23 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.95 | $0.61 |
| 52 Week High | $4.18 | $7.00 |
| Indicator | ALUR | DLXY |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 54.15 |
| Support Level | $1.05 | $0.84 |
| Resistance Level | $1.41 | $1.00 |
| Average True Range (ATR) | 0.14 | 0.10 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 37.14 | 40.84 |
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Delixy Holdings Ltd a holding company that operates through subsidiary. It is engaged in the trading of oil-related products, which can be categorized into crude oil, and oil-based products such as naphtha, motor gasoline, gas oil, fuel oil, asphalt, base oil, and other petrochemicals. The company has two reportable segments: the Sale of crude oil and the Sale of oil-based products. Key revenue is generated from the Sale of crude oil.